Objectives
In this webinar, key experts in the field from Europe and China, will discuss the importance of CRP levels in predicting treatment response in active axSpA. It is widely believed that CRP levels are always elevated in these patients; however, up to 59% of patients with active axSpA may have normal CRP, and the disease burden is independent of baseline CRP in active axSpA.
We will review how CRP levels are a good predictor of response to TNFi or IL-17i in axSpA patients, using guidelines, RCT data, and clinical experience as the evidence and support.
Lastly, a clinical case will be showcased, and you will have the opportunity to discuss live or ask any questions you may have to our panel of experts.
This Course For :
Physician
( Rheumatology )
Resident / Fellow
( Rheumatology )
Speaker
.png "Prof. Xenofon Baraliakos")
Prof. Xenofon Baraliakos
Head of Rheumatology at the Rheumazentrum Ruhrgebiet,
Herne, and Professor for Internal Medicine and Rheumatology at the Ruhr-University Bochum, Germany
Prof. XUE Yu
Chief physician of the Department of Rheumatology, Huashan
Hospital, Fudan University, China.
Prof. Pedro Machado
Professor of Rheumatology and Neuromuscular Diseases and Consultant Rheumatologist at University College London (UCL), University College London Hospitals (UCLH) and Northwick Park Hospital, United Kingdom.
Price
Course Fee
FREE
FREE
Contact Information
Organization : Virtual Medical AcademyPhone : 920008161
Email : [email protected]
Free
20 Feb 2025 To 20 Feb 2025 -
12:00 PM To 01:00 PM 
Certificate Available 
Online Click Here
- 33
Add to Calendar
02/20/2025 12:00 PM
02/20/2025 01:00 PM
Asia/ Riyadh
Taltz® in active axSpA – Proven efficacy in normal and elevated CRP levels
Taltz® in active axSpA – Proven efficacy in normal and elevated CRP levels
https://medicalacademy.org/portal/event/view/2332
